Argenta and Pcovery Announce Drug Discovery Collaboration

18-Jul-2013 - United Kingdom

Argenta announced that it has signed a collaboration agreement with Pcovery. Under the terms of the agreement, Argenta will provide medicinal chemistry and computer-aided drug design services, together with its integrated drug discovery expertise, to assist Pcovery in the identification of novel anti-fungal agents with the aim of discovering a development candidate that can be progressed into clinical trials.  The collaboration is funded by a Wellcome Trust Seeding Drug Discovery (SDD) award.

Other news from the department business & finance

More news from our other portals

All FT-IR spectrometer manufacturers at a glance